Meningo-Coccal Polysaccharide Diphtheria Toxoid Conjugate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 4 mcg
Reference Brands: Menactra (USA), Menveo (USA/EU), Nimenrix (LATAM)
Category: Vaccines
Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the bacteria.
Product Description:
Meningococcal infection can cause life-threatening illnesses, such as meningococcal meningitis, which affects the brain, and meningococcemia, which affects the blood. Some persons with meningococcal meningitis and/or meningococcemia may die. The rate of these diseases peak in adolescence and early adulthood and are more likely to occur in persons with certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine is used to prevent meningococcal disease caused by Neisseria meningitidis. It helps protect against serious infections such as meningitis and bloodstream infections that can lead to severe complications or death.
This vaccine is made from purified capsular polysaccharides of Neisseria meningitidis bacteria that are chemically linked to diphtheria toxoid protein. The conjugation improves the immune response, particularly in children and adolescents.
Common trade names include Menactra, Menveo, and Nimenrix.
This vaccine is manufactured by pharmaceutical companies such as Sanofi Pasteur, GlaxoSmithKline (GSK), and Pfizer.
The generic name is meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
Brand names include Menactra, Menveo, and Nimenrix.
This vaccine is manufactured in several countries including the United States, Italy, Belgium, and other regions depending on the manufacturer.Menactra
Related Products
Respiratory Syncytial Virus Mrna Vaccine
Strength:
0.5 mL
Form: injection (prefilled syringe)
Reference Brands: mRESVIA (USA/EU)
View Details
Inactivated Vaccines
Strength:
Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details
Viral Vector Vaccines
Strength:
0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details
Mrna-Based Vaccines
Strength:
30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
